Diab A, Hurwitz ME, Cho DC, et al. NKTR-214 (CD122-biased agonist) plus nivolumab in patients with advanced solid tumors: Preliminary phase 1/2 results of PIVOT. J Clin Oncol 36, 2018 (suppl; abstr 3006)
Geen verhoogd risico op andere kanker bij lynchsyndroom
sep 2018 | Gynaecologische oncologie, Maag-darm-leveroncologie